Patent Application
App. No. 16/857,167
SUSTAINED RELEASE BUPRENORPHINE MICROSPHERES (SRBM) AND METHODS OF USE THEREOF
Loading inventors, assignments & file history…
Abstract
The present invention is directed to a sustained release buprenorphine microsphere (SRBM) formulation capable of delivering buprenorphine, a metabolite, or a prodrug thereof for a duration of about 7 days to about 6 months.
Claims (2)
1 . A method for treating opioid dependence and/or pain in a subject comprising, administering a therapeutically effective amount of a sustained release buprenorphine microsphere (SRBM) formulation, wherein the formulation comprises: buprenorphine and poly(D,L-lactide-co-glycolide) having a MW of 24,000-38,000, wherein the plasma concentration does not exceed 10 ng/ml in the 12 hours after administration.
2 .- 56 . (canceled)
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 3, 2023
From: FINN, ANDREW; VASISHT, NIRAJ
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 062583/0508 →